Diflucortolone
As of the edition of 20 October 2026, Diflucortolone is a small molecule: marketed, first approved in 1978 (FR).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1979
- Kind
- Small molecule
- Brand name
- Nerisone Gras
- First approved
- 7 August 1978 (FR)
- Approvals on record
- 2 in 2 regions
- Holder of the most recent approval
- LEO Pharma; 2 holders in all
- Registered trials
- 2, 0 stopped early
- Disease areas
- Immune system; Inherited and neonatal; Skin and connective tissue
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 2 | 2 | 0 | 0 |
| All trials | 2 |
Who ran its trials
| Company | Role | Years |
|---|---|---|
| LEO Pharma | Lead sponsor of trials | 2015 to now |